Connie Cook
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations.
Across 255 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$552
- AstraZeneca$458
- Pfizer$453
- AbbVie$427
- Novo Nordisk$347
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$241
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,873100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 34 | $552 |
| AstraZeneca | 29 | $458 |
| Pfizer | 47 | $453 |
| AbbVie | 24 | $427 |
| Novo Nordisk | 19 | $347 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $241 |
| Sumitomo Pharma America, Inc. | 13 | $209 |
| Abbott | 9 | $177 |
| Boehringer Ingelheim | 11 | $163 |
| Lilly USA, LLC | 9 | $160 |
| Amarin Pharma, Inc. | 9 | $118 |
| Amgen | 4 | $67 |
| Xeris Pharmaceuticals, Inc. | 3 | $66 |
| Dexcom, Inc. | 4 | $65 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Verona Pharma, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $51 |
| Almatica Pharma LLC | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Johnson & Johnson | 3 | $40 |
| Bayer | 2 | $33 |
| Merck | 2 | $31 |
| Ardelyx, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$3,873 in reported general payments places this provider in the 80th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 78 | $86,757 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 85 | $65,273 |
| MounjaroTirzepatide | 39 | $44,342 |
| JardianceEmpagliflozin | 51 | $42,164 |
| FarxigaDapagliflozin Propanediol | 48 | $41,764 |
| EliquisApixaban | 46 | $33,867 |
| TrulicityDulaglutide | 31 | $28,197 |
| BrilintaTicagrelor | 21 | $17,106 |
| EntrestoSacubitril/Valsartan | 20 | $16,821 |
| VascepaIcosapent Ethyl | 21 | $13,935 |
| LinzessLinaclotide | 23 | $12,212 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 367 | $12,207 |
| XareltoRivaroxaban | 19 | $11,941 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 66 | $9,596 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 263 | $8,807 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $347 | $86,75778 claims |
| Lilly USA, LLCMounjaro, Trulicity | $160 | $72,54070 claims |
| GSKTrelegy Ellipta | $552 | $65,27385 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $458 | $62,49282 claims |
| Boehringer IngelheimJardiance | $163 | $42,16451 claims |
| PfizerEliquis, Paxlovid | $453 | $35,22059 claims |
| AbbVieLinzess, Synthroid | $427 | $13,38539 claims |
| Johnson & JohnsonXarelto | $40 | $11,94119 claims |
| MerckJanuvia | $31 | $5,92711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 233 medical providers in West Virginia.
Other medical in Man
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
- Mohammad YousafCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.